Dr. Anusha Sunder*

Doctorate in Life Science/Human Nutrition, Accredited Certification in Nutrigenetics; Lead Scientist and Nutrigenetic Expert, Xcode Life Sciences, Pvt. Ltd. Chennai, India

*Corresponding Author: Dr. Anusha Sunder, Doctorate in Life Science/Human Nutrition, Accredited Certification in Nutrigenetics; Lead Scientist and Nutrigenetic Expert, Xcode Life Sciences, Pvt. Ltd. Chennai, India.

Received: May 14, 2024; Published: June 28, 2024

Abstract

Coffee is the most popular social drink, owing to its refreshing aroma and tiredness-averting qualities. One cup of coffee contains approximately 96 mg of caffeine. Generally, healthy adults can tolerate up to 400 mg of caffeine in a day (which equates to 2-3 cups of coffee/tea). But in some people caffeine is retained in the blood for a longer time due to certain unfavorable genetic changes, leading to caffeine-associated health risks such as sleep deprivation, anxiety, hypertension, and palpitation. Precisely addressing the underlying genetic cause will aid in effectively managing caffeine-associated health risks through subjective quantification of caffeine and alternating the extra cup of coffee with another refreshing beverage [1,2].

 Keywords: Caffeine; Gene; Allele; Single Nucleotide Polymorphism/SNP; CYP1A2 (Cytochrome Enzyme P-450 1A2); Fast/Rapid Metabolizers; Intermediate Metabolizers; Slow Metabolizers; Sleep Latency; Insomnia; ACE/Angiotensin Converting Enzyme

References

1. Kole J and Barnhill A. “Caffeine Content Labeling: A Missed Opportunity for Promoting Personal and Public Health”. Journal of Caffeine Research 3.3 (2013): 108-113.
2. Juliano LM and Griffiths RR. “Caffeine”. In: Substance Abuse: A Comprehensive Textbook, Fourth Edition, Lowinson JH, Ruiz P, Millman RB, Langrod JG (Eds), Baltimore: Lippincott Williams, & Wilkins, (2005).
3. Aronica L., et al. “Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine”. Nutrients 14.4 (2022): 768.
4. Faber MS., et al. “Assessment of CYP1A2 activity in clinical practice: why, how, and when?” Basic & Clinical Pharmacology & Toxicology3 (2005): 125-134.
5. Barrangou-Poueys-Darlas M., et al. “CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation”. Drug Metabolism Reviews1 (2021): 30-44.
6. Sachse C., et al. “Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine”. British Journal of Clinical Pharmacology4 (1999): 445-449.
7. Yang A., et al. “Genetics of caffeine consumption and responses to caffeine”. Psychopharmacology 3 (2010): 245-257.
8. Byrne EM., et al. “A genome-wide association study of caffeine-related sleep disturbance: confirmation of a role for a common variant in the adenosine receptor”. Sleep7 (2012): 967-975.
9. Drake C., et al. “Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed”. Journal of Clinical Sleep Medicine 11 (2013): 1195-1200.
10. Lyons CL and Roche HM. “Nutritional Modulation of AMPK-Impact upon Metabolic-Inflammation”. International Journal of Molecular Sciences 10 (2018): 3092.
11. Jafaripour L., et al. “The effect of gallic acid on memory and anxiety-like behaviors in rats with bile duct ligation-induced hepatic encephalopathy: Role of AMPK pathway”. Avicenna Journal of Phytomedicine4 (2022): 425-438.
12. Kujawska A., et al. “Coffee Consumption and Blood Pressure: Results of the Second Wave of the Cognition of Older People, Education, Recreational Activities, Nutrition, Comorbidities, and Functional Capacity Studies (COPERNICUS)”. Nutrients10 (2021): 3372.
13. Soares RN., et al. “The influence of CYP1A2 genotype in the blood pressure response to caffeine ingestion is affected by physical activity status and caffeine consumption level”. Vascular Pharmacology 106 (2018): 67-73.
14. Palatini P., et al. “CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension”. Journal of Hypertension8 (2019): 1594-1601.
15. Hou CC., et al. “Association between hypertension and coffee drinking based on CYP1A2 rs762551 single nucleotide polymorphism in Taiwanese”. Nutritional Metabolism (Lond).1 (2021): 78.
16. Voskoboinik A., et al. “Caffeine and Arrhythmias: Time to Grind the Data”. JACC Clinical Electrophysiology4 (2018): 425-432.
17. Thorn CF., et al. “PharmGKB summary: very important pharmacogene information for CYP1A2”. Correction Appears in Pharmacogenet Genomics 9 (2019): 224.
18. Cornelis MC., et al. “Coffee, CYP1A2 genotype, and risk of myocardial infarction”. JAMA10 (2006): 1135-1141.
19. Cornelis MC., et al. “Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction”. Journal of Medical Genetics 10 (2004): 758-762.
20. Banks NF., et al. “Genetic Polymorphisms in ADORA2A and CYP1A2 Influence Caffeine’s Effect on Postprandial Glycaemia”. Scientific Report9 (2019):
21. Lane JD., et al. “Caffeine impairs glucose metabolism in type 2 diabetes”. Diabetes Care8 (2004): 2047-2048.
22. Hallström H., et al. “Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study”. Nutritional Metabolism (Lond)7 (2010): 12 (2010).
23. Cagri Baris Gunec. “A Mini Review on The Relationship Between Coffee And Tea Consumption And Iron Absorption in The Gut - Iron Deficiency Anemia”. Japan Journal of Clinical and Medical Research. SRC/JJCMR-156 (2023).
24. Mascitelli L., et al. “Inhibition of Iron Absorption by Coffee and the Reduced Risk of Type 2 Diabetes Mellitus”. Archives of Internal Medicine2 (2007): 204-205.
25. Fleming DJ., et al. “Dietary determinants of iron stores in a free-living elderly population: The Framingham Heart Study”. The American Journal of Clinical Nutrition4 (1998): 722-733.
26. Morck TA., et al. “Inhibition of food iron absorption by coffee”. The American Journal of Clinical Nutrition3 (1983): 416-420.
27. Gkouskou KG., et al. “CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study”. International Journal of Obesity (Lond). 46.1 (2022): 162-168.
28. Schubert MM., et al. “Caffeine, coffee, and appetite control: a review”. International Journal of Food Sciences and Nutrition 8 (2017): 901-912.
29. Grgic J., et al. “CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance”. Journal of the International Society of Sports Nutrition 1 (2020): 21.
30. Guest NS., et al. “Sport Nutrigenomics: Personalized Nutrition for Athletic Performance”. Frontiers in Nutrition 6 (2019): 8.

Citation

Citation: Dr. Anusha Sunder. “How Much of Coffee is Risk-Free for You? The Answer Lies in Your Genes”.Acta Scientific Medical Sciences 8.7 (2024): 243-249.

Copyright

Copyright: © 2024 Dr. Anusha Sunder. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.